Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Market Vectors Biotech ETF

+ Add to Watchlist

BBH:US

129.3600 USD 0.1500 0.12%

As of 20:04:01 ET on 03/26/2015.

Snapshot for Market Vectors Biotech ETF (BBH)

Open: 127.9600 High - Low: 130.8400 - 126.8600 Primary Exchange: NYSE Arca
Volume: 245,439 52-Week Range: 80.0500 - 140.7200 Beta vs MVBBHTR: 1.0006

ETF Chart for BBH

No chart data available.
  • BBH:US 129.3600
  • 1D
  • 1M
  • 1Y
129.5100
Interactive BBH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BBH

Market Vectors Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to track the performance of the US Listed Biotech 25 Index.

Inception Date: 2011-12-21 Telephone: 1-212-293-2000
Managers: PETER LIAO / GEORGE CAO
Web Site: www.vaneck.com

Fundamentals for BBH

NAV (on 2015-03-26) 129.4584
Assets (M) (on 2015-03-26) 782.7709
Shares out (M) 6.05
Market Cap (M) 782.18
% Premium -0.08
Average 52-Week % Premium -0.0060
Fund Leveraged N

Dividends for BBH

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2013-12-23) 0.0030
Dividend Yield (ttm) -%

Performance for BBH

1-Month +0.12% 1-Year +42.80%
3-Month +10.94% 3-Year +43.45%
Year To Date +12.12% 5-Year -
Expense Ratio 0.35

Top Fund Holdings for BBH

Filing Date: 03/25/2015
Name Position Value % of Total
Gilead Sciences Inc 1,100,122 109,858,183 14.012%
Amgen Inc 591,660 95,032,429 12.121%
Celgene Corp 730,967 85,515,829 10.907%
Biogen Inc 161,259 69,604,222 8.878%
Regeneron Pharmaceuticals Inc 91,858 41,702,613 5.319%
BioMarin Pharmaceutical Inc 306,670 35,457,185 4.522%
Alexion Pharmaceuticals Inc 196,289 34,474,237 4.397%
Vertex Pharmaceuticals Inc 286,190 33,953,582 4.331%
Illumina Inc 184,500 33,815,160 4.313%
Medivation Inc 248,588 32,323,898 4.123%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil